Israel Biotech Fund GP Partners, L.P.

USReporting entityDirector

Transactions

Issuers

Buys / Sells

10/0

Last tx

07 Feb 2024

FrançaisSign in Try free 14d

Insider

Israel Biotech Fund GP Partners, L.P.

USReporting entityDirector

Transactions

Issuers

Buys / Sells

10/0

Last tx

07 Feb 2024

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Advaxis, Inc.	19,655,308	reported	07 Feb 2024	tx 24+69,959,659−33,141,645

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.

1 month

−14.1%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

3 months

−34.3%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

6 months

−27.7%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,926,221	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	4,237,687	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	3,887,438	0.40 USD
07 Feb 2024	TAX_WITHHOLDING	Advaxis, Inc.	2,586,905	1.25 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,437,500	0.40 USD
07 Feb 2024	TAX_WITHHOLDING	Advaxis, Inc.	2,707,581	1.25 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,062,500	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,295,813	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	3,887,438	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,062,500	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,295,813	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,437,500	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,926,221	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	4,237,687	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	3,150,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	3,150,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	4,687,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	5,625,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	—	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	—	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	2,812,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	6,187,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	6,187,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	10,312,500	—	deriv

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.

1 month

−14.1%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

3 months

−34.3%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

6 months

−27.7%

Sample10

Win rate (≥5%)0%

Hit rate (>0)0%

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Advaxis, Inc.	19,655,308	reported	07 Feb 2024	tx 24+69,959,659−33,141,645

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,926,221	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	4,237,687	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	3,887,438	0.40 USD
07 Feb 2024	TAX_WITHHOLDING	Advaxis, Inc.	2,586,905	1.25 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,437,500	0.40 USD
07 Feb 2024	TAX_WITHHOLDING	Advaxis, Inc.	2,707,581	1.25 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,062,500	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,295,813	0.40 USD
07 Feb 2024	EXERCISE	Advaxis, Inc.	3,887,438	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,062,500	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,295,813	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	8,437,500	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	1,926,221	—	deriv
07 Feb 2024	EXERCISE	Advaxis, Inc.	4,237,687	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	3,150,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	3,150,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	4,687,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	5,625,000	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	—	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	—	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	2,812,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	6,187,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	6,187,500	—	deriv
17 Nov 2023	PURCHASE	Advaxis, Inc.	10,312,500	—	deriv